Mirum Pharmaceuticals, Inc. Expense Breakdown
No Expense Breakdown for MIRM on this site yet.
- 2026-06-30: Reportable $23.66M.
- 2025-06-30: Reportable $17.53M.
Source checked: the stored Expense Breakdown page for MIRM.
Expenses by product
Cost Of Goods And Service Excluding Depreciation Depletion And Amortization: each quarter (3 month)
| Quarter end | Reportable |
|---|
| 2026-06-30 | $23.66M |
|---|
| 2025-06-30 | $17.53M |
|---|
General and Administrative Expense: each quarter (3 month)
| Quarter end | Reportable |
|---|
| 2026-06-30 | $17.38M |
|---|
| 2025-06-30 | $13.09M |
|---|
Research And Development Expense Acquired In Process Cost: each quarter (3 month)
| Quarter end | Reportable |
|---|
| 2026-06-30 | $16.43M |
|---|
| 2025-06-30 | $0.00 |
|---|
Research And Development Expenses Excluding Stock Based Compensation: each quarter (3 month)
| Quarter end | Reportable |
|---|
| 2026-06-30 | $76.30M |
|---|
| 2025-06-30 | $38.44M |
|---|